Introducing https://t.co/XxDkcNqCx8
A curated community for the top EU operators building and scaling AI-native companies.
Handpicked 1:1 peer matching, curated resources, and member sessions showing what they are building.
Apply to join us!
Haven't posted on X since 2019, so let's make it count.
I lead Ops and Internal AI at Ramp. AI usage at Ramp is up 6,300% year over year with 99.7% of employees active on AI tools. We're shipping 1,000+ internal apps and agents every month, mostly with non-engineers. 12% of all PRs to our production codebase now come from people who aren't engineers. It's chaotic, exhilarating, and still in the early innings.
I wrote about how we got here — no dedicated team, no real budget, just a culture that turned out to be the right raw material and a lot of compounding.
https://t.co/TIxKSrTuHi
I'm the COO of @MiLaboratories and with our software you can process all the data, set up the bioinformatics pipeline and design the vaccine. If you want to do this for your pet now or in the future, let me know and I will give you access for free.
Australian tech entrepreneur Paul Conyngham explains how he used ChatGPT/AlphaFold (spent $3,000 with no biology background) to create a custom MRNA vaccine to treat his dog’s cancer tumors. Unreal.
@jaimenovoa Que me dices de todas las empresas con cláusulas en las que tienes que ejecutar la opción de compra de tus acciones al irte o quedarte sin ellas? Sin saber si eso llegará a valer algo algún día.